Phenylketonuria (PKU) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Phenylketonuria is a genetic disorder, which means it is inherited from one’s parents. In this disease, the patient suffers from a metabolic defect, wherein the body is unable to break down phenylalanine amino acid that is made of protein. Phenylalanine starts accumulating in the blood stream and eventually, it damages the brain. This happens due to mutations in the PAH gene, which result in low levels of the enzyme called phenylalanine hydroxylase. Intellectual impairment, hyperactivity, and mental health disorder are neurological symptoms of phenylketonuria. Skin rashes and order on the skin are physiological symptoms of the disease. If both parents are carriers of PKU, there exists a 25% possibility that their child would be conceived with the confusion; a 50% possibility that the kid would be a transporter; and a 25% possibility that it would neither create nor transport the illness. The fundamental approach to treat PKU is to eat a special diet that cuts off the food containing phenylalanine. Newborn children with PKU can be fed with breast milk. They for the most part likewise need to expend an uncommon recipe known as Lofenalac. At the point of the time when the child has grown enough to eat solid food, giving it a chance to eat foods high in protein needs to be avoided.
Based on type, the phenylketonuria market has been segmented into classic PKU, mild PKU, and benign PKU. Moreover, classic PKU is most common type of phenylketonuria, which results in severe brain damage. Based on test, the phenylketonuria market has been divided into diagnostic test and screening test. The screening test segment is expanding at a rapid pace, as the screening test helps detect the disease at its earliest and most treatable stage, especially for the newborn baby. Based on treatment, the phenylketonuria market has been segmented into drug therapy, dietary therapy, gene therapy, and others. Furthermore, the drug therapy segment has been sub-divided into oral therapy and parenteral therapy. The drug therapy segment is expanding by holding a large market share, as external drugs such as sapropterin dihydrochloride are required to combat the disease. The drug therapy works effectively fulfilling the requirements and maintaining the phenylalanine level in the blood. The market for phenylketonuria in developed economies is witnessing growth, owing to the large number of patients suffering from phenylketonuria, high awareness about the disease, and high diagnostic rate of the disease in these countries. However, issues related to newborn screening is a factor that restricts the phenylketonuria market.
Based on geography, the global phenylketonuria market has been segmented into North America, Europe, Asia Pacific, Latin America, and MEA. The North America phenylketonuria treatment market is expected to hold a high market share during the forecast period, due to the rising number of newborns suffering from phenylketonuria in the region. The rise in awareness among people and improved health care infrastructure in Europe boost the market in the region. The market in Asia Pacific is projected to expand at a significant rate during the forecast period, due to large pool of patients and increase in R&D activities for the development of drugs for phenylketonuria in the region. Moreover, growing economy and availability of newborn screening infrastructure and different screening programs augment the phenylketonuria market in Middle East & Africa.
Some of the key players operating in the global phenylketonuria market are American Gene Technologies International Inc., Dimension Therapeutics, Inc., BioMarin Pharmaceutical Inc., Synthetic Biologics, Inc., Codexis, Inc., SOM Innovation Biotech SL, Daiichi Sankyo Company, Limited, and Erytech Pharma SA.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017